News
4d
Capital Brief on MSNLumos Diagnostics shares soar 155% after $487m dealLumos Diagnostics' shares more than doubled in value in afternoon trade after the biotech announced a US$317 million ($487 ...
Soligenix (NASDAQ: SNGX) , a late-stage biopharmaceutical company targeting rare diseases, was spotlighted in a July 10 Zacks Small-Cap Research repo ...
Moderna stock has faced heavy pressure from negative headlines, regulatory setbacks and political uncertainty. See why I ...
5d
Zacks Small Cap Research on MSNNNVC: NanoViricides Set to Initiate Phase 2 Trial in MPoxNNVC NanoViricides, Inc. (NYSE:NNVC) is a clinical-stage biopharmaceutical company developing a new class of broad-spectrum ...
Detailed price information for Salarius Pharmaceuticals Inc (SLRX-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results